Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC000962

Drug Information
NameMRS-2179
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C11H17N5O9P2.2H3N/c1-12-10-9-11(14-4-13-10)16(5-15-9)8-2-6(25-
27(20,21)22)7(24-8)3-23-26(17,18)19;;/h4-8H,2-3H2,1H3,(H,12,13,14
)(H2,17,18,19)(H2,20,21,22);2*1H3/t6-,7+,8+;;/m0../s1
InChIKeyGAQWEBYIOMWWHZ-ZJWYQBPBSA-N
Canonical SMILESCNC1=NC=NC2=C1N=CN2C3CC(C(O3)COP(=O)(O)[O-])OP(=O)(O)[O-].[NH4+].[NH4+]    
Isomeric SMILESCNC1=NC=NC2=C1N=CN2[C@H]3C[C@@H]([C@H](O3)COP(=O)(O)[O-])OP(=O)(O)[O-].
[NH4+].[NH4+]
CAS NumberCAS 63142-71-2
PubChem Compound IDCID 5311302.
PubChem Substance IDSID 7980040.
SuperDrug ATC IDJ05AB04
SuperDrug CAS ID036791045;
TargetP2Y purinoceptor 1Antagonist[1][2]
Ref 1The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179. Cardiovasc Drug Rev. 2003 Spring;21(1):67-76. To Reference
Ref 2Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist. J Thromb Haemost. 2003 Jun;1(6):1144-9. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543